Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (41-50 of 426) with videos related to

Pageof 43
Sort By:
European Journal of Medicinal Chemistry|August 18, 2019
Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitorsYali Sang, Sheng Han, Christophe Pannecouque, et al.
Antiviral Chemistry & Chemotherapy|October 3, 2007
Nitroimidazoles Part 6. Synthesis, structure and in vitro anti-HIV activity of new 5-substituted piperazinyl-4-nitroimidazole derivativesNajim A Al-Masoudi, Yaseen A Al-Soud, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|December 21, 2006
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agentsRavindra K Rawal, Rajkamal Tripathi, S B Katti, et al.
Bioorganic & Medicinal Chemistry|February 13, 2008
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsYue-Ping Wang, Fen-Er Chen, Erik De Clercq, et al.
Molecules (Basel, Switzerland)|February 21, 2017
Application of the Triazolization Reaction to Afford Dihydroartemisinin Derivatives with Anti-HIV ActivitySampad Jana, Shabina Iram, Joice Thomas, et al.
Bioorganic & Medicinal Chemistry|October 13, 2009
Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIsMingyan Yu, Xinyong Liu, Zhenyu Li, et al.
Journal of Medicinal Chemistry|October 1, 2024
Fragment Addition-Based Design of Heteroaromatic-Biphenyl-DAPYs as Potent and Orally Available Non-nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Enhanced SafetyWen-Juan Huang, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry|March 13, 2012
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitorsXuwang Chen, Peng Zhan, Christophe Pannecouque, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitorsPeng Zhan, Xinyong Liu, Yuan Cao, et al.
Journal of Medicinal Chemistry|November 13, 2019
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic ProfilesYali Sang, Sheng Han, Christophe Pannecouque, et al.
Pageof 43

Showing results (41-50 of 426) with videos related to

Sort By:
Pageof 43
European Journal of Medicinal Chemistry|August 18, 2019
Conformational restriction design of thiophene-biphenyl-DAPY HIV-1 non-nucleoside reverse transcriptase inhibitorsYali Sang, Sheng Han, Christophe Pannecouque, et al.
Antiviral Chemistry & Chemotherapy|October 3, 2007
Nitroimidazoles Part 6. Synthesis, structure and in vitro anti-HIV activity of new 5-substituted piperazinyl-4-nitroimidazole derivativesNajim A Al-Masoudi, Yaseen A Al-Soud, Erik De Clercq, et al.
Bioorganic & Medicinal Chemistry|December 21, 2006
Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agentsRavindra K Rawal, Rajkamal Tripathi, S B Katti, et al.
Bioorganic & Medicinal Chemistry|February 13, 2008
Synthesis and biological evaluation of novel 6-substituted 5-alkyl-2-(arylcarbonylmethylthio)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsYue-Ping Wang, Fen-Er Chen, Erik De Clercq, et al.
Molecules (Basel, Switzerland)|February 21, 2017
Application of the Triazolization Reaction to Afford Dihydroartemisinin Derivatives with Anti-HIV ActivitySampad Jana, Shabina Iram, Joice Thomas, et al.
Bioorganic & Medicinal Chemistry|October 13, 2009
Synthesis and biological evaluation of novel 2-(substituted phenylaminocarbonylmethylthio)-6-(2,6-dichlorobenzyl)-pyrimidin-4(3H)-ones as potent HIV-1 NNRTIsMingyan Yu, Xinyong Liu, Zhenyu Li, et al.
Journal of Medicinal Chemistry|October 1, 2024
Fragment Addition-Based Design of Heteroaromatic-Biphenyl-DAPYs as Potent and Orally Available Non-nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Enhanced SafetyWen-Juan Huang, Christophe Pannecouque, Erik De Clercq, et al.
European Journal of Medicinal Chemistry|March 13, 2012
Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitorsXuwang Chen, Peng Zhan, Christophe Pannecouque, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2008
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitorsPeng Zhan, Xinyong Liu, Yuan Cao, et al.
Journal of Medicinal Chemistry|November 13, 2019
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic ProfilesYali Sang, Sheng Han, Christophe Pannecouque, et al.
Pageof 43